Glucagon-like peptide 1 and its effects GLP-1 is an stimulating insulin release inhibiting glucagon release slowing gastric emptying reducing appetite by increasing satiety These GLP-1 effects may be impaired or absent in people with type 2 diabetes
One strategy is to rotate the application site when using a patch to avoid skin irritation
The most commonly reported side effects are gastrointestinal in nature , including nausea, vomiting, diarrhoea, constipation, and abdominal discomfort
For breast cancer patients, this includes knowing the type and stage of cancer, the treatments being used, and how well the patient is responding to those treatments
If you have UHC insurance through your workplace, contact your insurance representative to obtain more information about this plan